BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27714856)

  • 1. High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.
    Omland SH; Hamrouni A; Gniadecki R
    Exp Dermatol; 2017 May; 26(5):454-456. PubMed ID: 27714856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immune response in cutaneous basal cell carcinoma.
    Omland SH
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
    Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor repertoires of ex vivo-expanded tumor-infiltrating lymphocytes from breast cancer patients.
    Park IA; Rajaei H; Kim YA; Lee H; Lee H; Seo JH; Heo SH; Song IH; Gong G; Lee HJ
    Immunol Res; 2020 Oct; 68(5):233-245. PubMed ID: 32886262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.
    Nakanishi K; Kukita Y; Segawa H; Inoue N; Ohue M; Kato K
    Cancer Med; 2016 Sep; 5(9):2513-21. PubMed ID: 27465739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAV gene expression in PBMCs and TILs in patients with breast cancer analyzed by a DNA melting curve (FQ-PCR) technique for TCR α chain CDR3 spectratyping.
    He XY; Yang WM; Tang WT; Ma R; Sun YP; Wang P; Yao XS
    Neoplasma; 2012; 59(6):693-9. PubMed ID: 22862170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective accumulation of T cells according to T-cell receptor V beta gene usage in skin cancer.
    Ohmen JD; Moy RL; Zovich D; Lieberman A; Wyzykowski RJ; Sullivan L; Modlin RL; Uyemura K
    J Invest Dermatol; 1994 Dec; 103(6):751-7. PubMed ID: 7798611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
    Nitta T; Bell R; Okumura K; Sato K; Steinman L
    Cancer Res; 1991 Oct; 51(20):5565-9. PubMed ID: 1655255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
    Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell receptor repertoire in tumor infiltrating lymphocytes within malignant brain tumors].
    Nitta T; Ikeda M; Cogen P; Steinman L; Sato K
    No Shinkei Geka; 1992 May; 20(5):559-66. PubMed ID: 1317945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
    Ebato M; Nitta T; Yagita H; Sato K; Okumura K
    Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
    Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A
    Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains.
    Kitaura K; Shini T; Matsutani T; Suzuki R
    BMC Immunol; 2016 Oct; 17(1):38. PubMed ID: 27729009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.
    Chen Z; Zhang C; Pan Y; Xu R; Xu C; Chen Z; Lu Z; Ke Y
    J Pathol; 2016 Aug; 239(4):450-8. PubMed ID: 27171315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
    Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
    Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R; Paucz L; Pehamberger H; Stingl G
    Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.
    Shi L; Zhang Y; Feng L; Wang L; Rong W; Wu F; Wu J; Zhang K; Cheng S
    Oncotarget; 2017 May; 8(21):34844-34857. PubMed ID: 28422742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.